Kynam Capital Management’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Kynam Capital Management’s Portfolio GBT Stock Details GBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-131,220	Closed	-$8.94M	–	42
2022 Q3	$8.94M	Sell	131,220 -2,068,780	-94%	-$114M	1.88%	16
2022 Q2	$70.3M	Buy	2,200,000 +860,678	+64%	+$25.2M	17.95%	1
2022 Q1	$46.4M	Buy	1,339,322 +346,373	+35%	+$10.4M	15.05%	1
2021 Q4	$29.1M	Buy	+992,949	New	+$30.8M	15.54%	1

Other funds holding GBT

BTI

Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Kynam Capital Management's GBT Position: Q4 2022 in Review

Kynam Capital Management sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 131,220 shares — an estimated $8.94M sold.

Kynam Capital Management first reported a position in GBT in Q4 2021 and held it in 4 quarters. The position peaked at $70.3M in Q2 2022. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

Kynam Capital Management reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
Kynam Capital Management sold 131,220 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $8.94M.
Kynam Capital Management first reported a position in Global Blood Therapeutics, Inc. in Q4 2021 and held it in 4 quarters.
Kynam Capital Management's Global Blood Therapeutics, Inc. position peaked at $70.3M in Q2 2022.
2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on Kynam Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.